Market Cap 6.92M
Revenue (ttm) 5.33M
Net Income (ttm) -13.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 42.67
Profit Margin -262.29%
Debt to Equity Ratio 0.00
Volume 5,700
Avg Vol 1,498,196
Day's Range N/A - N/A
Shares Out 1.37M
Stochastic %K 32%
Beta 0.90
Analysts Strong Sell
Price Target $12.00

Latest News on RKDA

Arcadia Biosciences (RKDA) Announces Leadership Transition

Jul 9, 2024, 8:02 AM EDT - 6 months ago

Arcadia Biosciences (RKDA) Announces Leadership Transition


Arcadia Biosciences, Inc. (RKDA) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 9:12 PM EDT - 10 months ago

Arcadia Biosciences, Inc. (RKDA) Q4 2023 Earnings Call Transcript


Arcadia Biosciences (RKDA) Announces Strategic Review

Jul 20, 2023, 8:02 AM EDT - 1 year ago

Arcadia Biosciences (RKDA) Announces Strategic Review


4 Cheapest Defensive Stocks You Should Think About

Feb 1, 2023, 7:18 AM EST - 2 years ago

4 Cheapest Defensive Stocks You Should Think About

LOCL


Arcadia Biosciences (RKDA) Announces CFO Transition

Nov 30, 2022, 4:30 PM EST - 2 years ago

Arcadia Biosciences (RKDA) Announces CFO Transition


Arcadia Biosciences Inc (RKDA) Q3 2022 Earnings Call Transcript

Nov 10, 2022, 6:54 PM EST - 2 years ago

Arcadia Biosciences Inc (RKDA) Q3 2022 Earnings Call Transcript